AVENUE THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-12-31 was $99.00K.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-09-30 was $0.00.
- AVENUE THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $299.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2017-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $299.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 |